Toxic Epidermal Necrolysis
📧 Sign up to get email alerts when something new happens for Toxic Epidermal Necrolysis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: G-CSF in the Treatment of Toxic Epidermal Necrolysis [Phase 4]
Phase 4 clinical trial update evaluating granulocyte colony-stimulating factor (filgrastim) for toxic epidermal necrolysis and Stevens-Johns…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: NATIENS: Optimal Management and Mechanisms of SJS/TEN [Phase 3]
Phase 3 clinical trial NATIENS for optimal management and mechanisms of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis has complete…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN [NA]
A completed clinical trial assessed the efficacy of tofacitinib in patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, wi…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: LYell SYndrome MEsenchymal Stromal Cells Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating adipose-derived mesenchymal stromal cells for Lyell syndrome/toxic epidermal necrolysis; recruitment i…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs
Completed clinical trial comparing immune checkpoint inhibitors versus non-ICI therapies for cutaneous adverse events, including Stevens-Joh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis [NA]
This clinical trial update describes a study of minor salivary gland transplantation for cicatricial conjunctivitis, sponsored by National T…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Palifermin for Toxic Epidermal Necrolysis and Stevens-Johnson syndrome was terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids. [Phase 3]
Phase III clinical trial of NPB-01 for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis unresponsive to corticosteroids has completed…